ANTI-GLYCO-CMET ANTIBODIES AND THEIR USES

ANTIBODIES SPECIFICALLY RECOGNIZING FCRN AND USES THEREOF

ANTI-B7-H7 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND PREPARATION METHOD THEREFOR AND USE THEREOF

DEVELOPMENT OF NOVEL PDL1 SINGLE-DOMAIN ANTIBODY

ANTI-B7-H4 ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF

MULTISPECIFIC BINDING PROTEIN COMPOSITIONS AND USES THEREOF

STABILIZED CD3 ANTIGEN BINDING AGENTS AND METHODS OF USE THEREOF

ANTI-HUMAN CD3 ANTIBODY AND USE THEREOF

ANTI-CD101 ANTIBODY AND USE THEREOF

TREM2 STABILIZING ANTIBODIES

OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF

Method of modulating autoimmunity by disrupting cis-ligand binding of siglec type antigens

NKp46-Binding Polypeptides and Uses Thereof

BISPECIFIC ANTIGEN-BINDING MOLECULE AND USE THEREOF

METHOD OF IMPROVING THE CONSISTENCY AND/OR QUALITY OF A FELINE ANTIBODY

ANTI-ANGPTL3 ANTIBODIES AND USES THEREOF

USAG-1 MOLECULE-TARGETING NEUTRALIZING ANTIBODY FOR TOOTH REGENERATION TREATMENT

ANTI-VEGF ANTIBODY CONSTRUCTS AND RELATED METHODS FOR TREATING VESTIBULAR SCHWANNOMA ASSOCIATED SYMPTOMS

THERAPIES FOR MUCOPOLYSACCHARIDOSIS TYPE 6

Monoclonal Antibodies Against Alpha-Synuclein Fibrils

VHH ANTIBODY

ANTIBODY SPECIFIC TO SPIKE PROTEIN OF SARS-COV-2 AND USES THEREOF

DUAL CYTOKINE FUSION PROTEINS COMPRISING IL-10

BISPECIFIC RECOMBINANT PROTEIN AND USE THEREOF

ANTI-PLASMA KALLIKREIN ANTIBODIES

ANTIBODIES BINDING TO HLA-A2/WT1

CDC Platform Antibody

PRLR ANTIGEN-BINDING PROTEIN, PREPARATION METHOD THEREFOR AND USE THEREOF

HUMAN CGRP RECEPTOR BINDING PROTEINS

DUAL SPECIFICITY ANTIBODIES TO PD-L1 AND PD-L2 AND METHODS OF USE THEREFOR

Antibodies Binding to Vista at Acidic pH

BUTYROPHILIN (BTN) 3A ACTIVATING ANTIBODIES FOR USE IN METHODS FOR TREATING INFECTIOUS DISORDERS

ANTI-PD-1 ANTIBODIES AND USES THEREOF

PHARMACEUTICAL COMPOSITION AND USE THEREOF

HIV Specific Binding Molecules and Uses Thereof

T CELL ENGAGER MOLECULES AND USES THEREOF

METHODS OF TREATING CANCER USING ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1

FUSION PROTEIN CONTAINING ANTI-TIGIT ANTIBODY AND TGF-ßR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF

CLAUDIN 6 ANTIBODIES AND USES THEREOF

ANTIBODIES THAT BIND INTERLEUKIN 13 AND METHODS OF USE

IMPROVED Fc SILENCED ANTI-oxMIF ANTIBODIES WITH REDUCED AGGREGATION POTENTIAL AND REDUCED HYDROPHOBICITY

BI- AND MULTIVALENT ALBUMIN BINDERS

MULTISPECIFIC ANTIBODIES AND USES THEREOF

ANTI-UBIQUITIN SYNTHETIC ANTIBODY

ANTIBODIES BINDING TO TETANUS TOXIN AND USES THEREOF

ANTIBODY FOR TETANUS TOXIN AND USE THEREOF

ANTI-HCMV ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF

METHODS AND COMPOSITIONS FOR TARGETING DISEASE RELATED CELL SURFACE RECEPTORS USING RADIOLABELED AND/OR CYTOTOXIN LABELLED ANTIBODIES

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

BOREALIN TARGETING POLYPEPTIDES FOR DETECTION AND TREATMENT OF CANCER

METHOD FOR HUMANIZING ANTIBODIES

FCRN/HSA BINDING MOLECULES AND METHODS OF USE

Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the Same

Anti-CTLA-4 Antibodies and Uses Thereof

ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-TISSUE FACTOR ANTIBODIES OR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES

BISPECIFIC ANTIGEN BINDING CONSTRUCTS TARGETING HER2

PRE-TARGETING

CD25 ANTIBODIES

ANTI-HUMAN CD45RC ANTIBODIES AND USES THEREOF

DEIMMUNIZED VNAR DOMAINS AND SCAFFOLDS

ANTI-EGFR/MET ANTIBODIES AND USES THEREOF

ANTI-TRKA ANTIBODIES AND USES THEREOF

ANTIBODY OPTIMIZATION

CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3

ANTI-INTERLEUKIN-9 ANTIBODY AND USE THEREOF

INTERLEUKIN-17 (IL-17) ANTAGONISTIC ANTIBODIES

ANTIBODY VARIANTS

Recombinant Fusion Proteins Comprising Interleukin- 18-Binding Protein and Antigen Binding Fragment to Serum Albumin, and Compositions and Uses Thereof

ANTI-ROR1 ANTIBODY, AND ANTI-ROR1 ANTIBODY-DRUG CONJUGATE AND MEDICAL USES THEREOF

GPRC5D ANTIBODY AND USE THEREOF

T CELL BINDING COMPOSITIONS AND METHODS

Anti-CEA Antibody Drug Conjugates and Methods of Use

ADAM9-Binding Molecules, and Methods of Use Thereof

ANTIBODY TARGETING B CELL MATURATION ANTIGEN AND RELATED PRODUCTS THEREOF AND MEDICAL APPLICATIONS

CANINE ANTI-NGF ANTIBODIES AND METHODS OF TREATING PAIN THEREOF

ANTI-CCR8 ANTIBODIES AND METHODS OF USE

BISPECIFIC ANTIBODY AGAINST ALPHA-SYN/IGF1R AND USE THEREOF

ANTIBODIES AGAINST TIM3 AND USES THEREOF

AGONISTIC ANTIBODIES THAT BIND CD40

BROADLY NEUTRALIZING ANTI-HIV ANTIBODIES AND EPITOPE THEREFOR

NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY

PHARMACEUTICAL COMBINATION CONTAINING ANTI-PD-1-ANTI-VEGFA BISPECIFIC ANTIBODY, AND USE THEREOF

Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS

HETERODIMERIC ANTIBODIES THAT BIND CD3 AND CD38

RECOMBINANT FUSION PROTEIN TARGETING CD40 AND CD47

TL1A ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE

TL1A ASSOCIATED ANTIBODY COMPOSITIONS AND METHODS OF USE

CHIMERIC HEAVY CHAIN CONSTANT DOMAINS WITH REDUCED BINDING TO FC GAMMA RECEPTORS AND USES THEREOF

ACTIVATABLE BISPECIFIC ANTI-CD3 AND ANTI-PD-L1 PROTEINS AND USES THEREOF

COMPOSITIONS COMPRISING ANTIBODIES THAT BIND GAMMA-DELTA T CELL RECEPTORS

Gamma Delta T-Cell-Targeted Modified IL-2 Polypeptides and Uses Thereof

ANTIBODIES AND ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 6

DUAL SPECIFIC ANTIBODIES

NOVEL ANTIGEN BINDING MOLECULE FORMATS

MYELOPROLIFERATIVE CONDITIONS

ANTI-SARS-CoV-2 SPIKE (S) ANTIBODIES AND THEIR USE IN TREATING COVID-19

SARS-CoV-2 BINDING PROTEINS AND METHODS OF USE THEREOF

METHODS, COMPOSITIONS AND KITS FOR TREATING A SUBJECT USING A RECOMBINANT HETEROMULTIMERIC NEUTRALIZING BINDING PROTEIN

ENHANCED TARGETING PLATFORM

ANTIGEN BINDING MOLECULES COMPRISING A TNF FAMILY LIGAND TRIMER

DEVELOPMENT OF NANOBODIES AS FIRST-IN-CLASS INHIBITORS FOR THE DENEDDYLATING ENZYME NEDP1

FACTOR XI ANTIBODIES AND METHODS OF USE

ANTI-GLYCO-MUC4 ANTIBODIES AND THEIR USES

METHOD OF TREATING IGA NEPHROPATHY BY ADMINISTERING ALTERED ANTIBODIES WHICH BIND HUMAN A PROLIFERATION-INDUCING LIGAND (APRIL) PROTEIN

ANTIBODY MOLECULES

ANTI-MET FAB-FC FOR THE TREATMENT OF A TUMOR AND/OR METASTASIS

METHODS OF TREATING DISORDERS ASSOCIATED WITH EXCESS OR UNWANTED KILLER CELL LECTIN-LIKE RECEPTOR SUBFAMILY G MEMBER 1 (KLRG1) EXPRESSING T CELLS WITH KLRG1 DEPLETING ANTIBODIES

FCRN ANTAGONISTS AND METHODS OF USE

ANTI-B7-H3 COMPOUNDS AND METHODS OF USE

BISPECIFIC MOLECULE WITH TUNABLE AFFINITY TO A TARGETED ANTIGEN

COMBINATIONS OF ANTIGEN BINDING MOLECULES

ANTI-NKG2A ANTIBODIES AND USES THEREOF

ANTIBODIES AND ANTIBODY CONJUGATES SPECIFIC FOR NECTIN-4 AND METHODS OF USE THEREOF

SHBG AND IBP4 ANTIBODIES AND METHODS USING SAME

METHODS, COMPOSITIONS AND DOSING REGIMENS FOR TREATING OR PREVENTING INTERFERON-GAMMA RELATED INDICATIONS

ANTI IL-6 DOMAIN ANTIBODIES

ANTI-IL-23 ANTIBODIES

COMPOUNDS AND METHODS TARGETING EPIREGULIN

ANTIBODY-PEPTIDE FUSION PROTEINS FOR TREATING AMYLOID DISORDERS

TAU THERAPY

HUMAN NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 HAVING BREADTH TO VARIANT STRAINS, AND ANTIGEN-BINDING FRAGMENT THEREOF

MASKED IL-2 CYTOKINES AND METHODS OF USE THEREOF

MULTISPECIFIC MOLECULES BINDING TO TCR AND USES THEREOF

T CELL ENGAGERS

METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF

HUMANIZED ANTI-CCR7 RECEPTOR ANTIBODIES

METHODS OF USE OF ANTI-SORTILIN ANTIBODIES FOR TREATING A DISEASE, DISORDER, OR INJURY

BISPECIFIC ANTIBODY BINDING TO B7H3 AND NKP30, AND APPLICATION THEREOF

HUMAN ANTIBODIES TO PD-L1

ANTIBODIES BINDING TO CD3

ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS FOR THE MODULATION OF BETA CHAIN-MEDIATED IMMUNITY

BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3

ANTI-ILT3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Anti-TREM1 Antibodies and Methods of Use Thereof

FOLR1 PROTEASE-ACTIVATABLE T CELL BISPECIFIC ANTIBODIES

ANTIBODY MOLECULE AGAINST GROWTH AND DIFFERENTIATION FACTOR 15 AND USE THEREOF

SINGLE-DOMAIN ANTIBODY AGAINST CPV AND USES THEREOF

IGG FC VARIANTS FOR VETERINARY USE

ANTI-CDH6 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES THEREOF

ANTI-FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES

BINDING DOMAINS AND METHODS OF USE THEREOF

METHODS FOR DETECTION OF MEMBRANE BOUND GLYPICAN-3

ANTI-CHITINASE-3-LIKE PROTEIN 1 ANTIBODY

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

METHODS OF USING BISPECIFIC ANTIGEN-BINDING CONSTRUCTS TARGETING HER2

ENGINEERED COMPOSITIONS FOR BONE-TARGETED THERAPY

ANTI-CD28 X ANTI-TROP2 ANTIBODIES

ANTI-CD98 ANTIBODIES AND USES THEREOF

THERAPEUTIC BINDING MOLECULES

TrkA ANTIBODY AND APPLICATION THEREOF

ANTIGEN BINDING PROTEINS

BISPECIFIC HUMANIZED SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47, AND USE THEREOF

NK/MONOCYTE ENGAGERS

COMPOSITIONS AND METHODS FOR MODULATING LAIR SIGNAL TRANSDUCTION

Antigen Binding Proteins That Bind ROR1

ANTI P2X7 RECEPTOR ANTIBODIES AND FRAGMENTS THEREOF

ANTIBODIES TARGETING CDH19 FOR MELANOMA

ANTI-CLL-1 ANTIBODIES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING SYNUCLEINOPATHIES

ANTI-HSP70 ANTIBODIES AND THERAPEUTIC USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD5+ CELLS

MUC16 CHIMERIC ANTIGEN RECEPTORS

CHIMERIC RECEPTORS

ANTI-MYOSTATIN ANTIBODIES, POLYPEPTIDES CONTAINING VARIANT FC REGIONS, AND METHODS OF USE

ANTI-GUCY2C NANO-ANTIBODY AND APPLICATION THEREOF

Dickkopf-1 Variant Antibodies and Methods of Use

MUC1 and CD16A Antibodies and Methods of Use

ANTI-GLYCO-MUC1 ANTIBODIES AND THEIR USES

ANTI-GPRC5DxBCMAxCD3 TRISPECIFIC ANTIBODY AND USE THEREOF

NOVEL DARPIN BASED CD70 ENGAGERS

ANTIBODIES TO CANINE AND FELINE ONCOSTATIN M RECEPTOR BETA AND USES THEREOF

COMPOSITIONS AND METHODS COMPRISING ANTI-NRP2 ANTIBODIES

PD-L1 ANTIGEN BINDING PROTEIN AND USE THEREOF

BISPECIFIC BINDING PROTEINS AND USES THEREOF

Humanized and Affinity-Matured Anti-CEACAM1 Antibodies

ANTIBODIES FOR IL-17C

Bone-Targeting Antibodies

GUCY2C ANTIBODIES AND USES THEREOF

ANTI-BETAKLOTHO ANTIBODY AND USE THEREOF

ANTI-MASP-2 ANTIBODY, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

BISPECIFIC ANTIBODIES AGAINST HER2

CELL INJURY INDUCING THERAPEUTIC DRUG FOR USE IN CANCER THERAPY

ANTIBODY BINDING TO HUMAN CD73, PREPARATION METHOD THEREFOR, AND USE THEREOF

ANTI-GLYCO-LAMP1 ANTIBODIES AND THEIR USES

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY POLYPEPTIDES

AGONISTIC ANTI TNFR2 ANTIBODY MOLECULES

ANTI-CD70 ANTIBODIES, CONJUGATES THEREOF AND METHODS OF USING THE SAME

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

ACTRIIB BINDING AGENTS AND USES THEREOF

USE OF INTEGRIN a5b1 INHIBITORS IN THE TREATMENT OF PULMONARY HYPERTENSION AND HEART FAILURE

ANTI-PD-L1 ANTIBODY, ANTI-PD-1 ANTIBODY, AND THE USE OF INHIBITOR TARGETING PD-1/PD-L1 AND COX-2 INHIBITOR

ANTIBODIES TARGETING PDL1 AND METHODS OF USE THEREOF

ANTIBODY MOLECULES TO PD-1 AND USES THEREOF

C-KIT ANTIBODIES

ANTIBODY TARGETING CD22 AND CD79B

TIGIT AND CD112R BLOCKADE

METHODS OF TREATING NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS USING INTERLEUKIN-17 (IL-17) ANTAGONISTS

Methods for Producing Anti-TNF Antibody Compositions

NUCLEIC ACID MOLECULES ENCODING ANTIBODIES TO A PROLIFERATION-INDUCING LIGAND (APRIL)

METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR

STABLE AND SOLUBLE ANTIBODIES INHIBITING VEGF

LINKABLE SINGLE DOMAIN ANTIBODIES THAT COVALENTLY BIND TO A TARGET ANTIGEN AND METHODS OF USE THEREOF

Bispecific Antibodies Specifically Binding to Klebsiella Pneumoniae O2 Antigen and O1 Antigen and Compositions Thereof

ANTI-SARS-CoV-2 SPIKE (S) ANTIBODIES AND THEIR USE IN TREATING COVID-19

NEUTRALISING ANTIBODIES AND USES THEREOF

HER2-TARGETING ANTIGEN BINDING MOLECULES COMPRISING 4-1BBL

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

PHARMACEUTICAL COMPOSITIONS COMPRISING ANTI-HUMAN TSLP RECEPTOR ANTIBODIES AND METHODS OF USING THE SAME

METHOD OF TREATING CANCER USING A COMBINATION OF ENTINOSTAT AND AN ANTI-CSF-1R ANTIBODY

ANTI-TIGIT ANTIBODIES

ANTIBODIES THAT BIND HUMAN C6 AND USES THEREOF

ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

ANTI-TIGIT ANTIBODIES AND USE THEREOF

Fusion Protein Construct

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

AGONISTIC CD28 ANTIGEN BINDING MOLECULES TARGETING HER2

Fusion Protein of Anti-Transferrin Receptor Antibody and Physiologically Active Protein for Safe Gene Therapy

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

GALECTIN-10 ANTIBODIES

CHIMERIC ANTIGEN RECEPTORS TARGETING FC RECEPTOR-LIKE 5 AND USES THEREOF

HIGH AFFINITY B7-H6 ANTIBODIES AND ANTIBODY FRAGMENTS

METHODS OF TREATING HUMAN IMMUNODEFICIENCY VIRUS (HIV) DISEASE

ANTIBODY TARGETING CD3, MULTISPECIFIC ANTIBODY, AND USES THEREOF

ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS

ANTIBODIES AND MOLECULES THAT IMMUNOSPECIFICALLY BIND TO BTN1A1 AND THE THERAPEUTIC USES THEREOF

TIGIT ANTIBODIES AND USES THEREOF

ANTI-FRa ANTIBODY, AND ANTIBODY-DRUG CONJUGATE AND USE THEREOF

HUMANIZED NON-OPIOID COMPOSITION AND THERAPIES FOR PAIN MANAGEMENT

IL-6 ANTIBODIES

ANTIBODIES FOR TREATING ALPHA-SYNUCLEINOPATHIES

ERYTHROCYTE-BINDING THERAPEUTICS

METHOD OF PREPARING PH-DEPENDENT ANTIBODIES

MULTI-SPECIFIC ANTIGEN BINDING MOLECULES TARGETING HIV AND METHODS OF USE

ANTI-DLL3 ANTIBODY AND PHARMACEUTICAL USE THEREOF, AND ANTIBODY-DRUG CONJUGATE CONTAINING ANTI-DLL3 ANTIBODY

CHIMERIC ANTIGEN RECEPTOR TARGETING GPRC5D AND APPLICATION THEREOF

CYTOTOXICITY TARGETING CHIMERAS FOR CXCR3-EXPRESSING CELLS

DLL3 BINDING MOLECULES AND USES THEREOF

ANTI-CD97 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

ANTI-CD38 BINDING MOLECULES AND USES THEREOF

ANTAGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY ANTIBODIES

ANTIBODY AGAINST OX40 AND MEDICAL USE THEREOF

FAP/CD40 BINDING MOLECULE AND MEDICINAL USE THEREOF

ANTIGEN-BINDING PROTEINS THAT ACTIVATE THE LEPTIN RECEPTOR

EPHA2 ANTIBODIES

ANTIBODIES AGAINST G-CSFR AND USES THEREOF

Methods for the treatment of thyroid eye disease

BISPECIFIC ANTI-VEGF AND ANTI-TRKB BINDING MOLECULES FOR THE TREATMENT OF EYE DISEASES

ASGR INHIBITORS

ANTI-HLA-G ANTIBODIES AND METHODS OF USE THEREOF

MULTISPECIFIC ANTIBODIES AND USE THEREOF

ANTIBODIES THAT TARGET HLA-E-HOST PEPTIDE COMPLEXES AND USES THEREOF

ANTI-B7-H3 MONOCLONAL ANTIBODY AND USE THEREOF IN CELL THERAPY

USE OF ANTI-PD-L1/CD47 BISPECIFIC ANTIBODY IN TREATMENT OF DISEASES

Anti-CD112R Compositions and Methods

Anti-CD28 Humanized Antibodies Formulated for Administration to Humans

BMA031 ANTIGEN BINDING POLYPEPTIDES

MULTI-SPECIFIC T CELL ENGAGERS COMPRISING LRRC15 ANTIGEN-BINDING DOMAIN

ANTI-CD3 MONOCLONAL ANTIBODIES AND THERAPEUTIC CONSTRUCTS

CDH17 ANTIBODIES AND METHODS OF TREATING CANCER

ANTI-IL-5 ANTIBODIES AND USES THEREOF

MONOVALENT INTERLEUKIN 12 (IL-12) HETERODIMERIC FC PROTEINS

NOVEL ANTI-TSLP ANTIBODIES

Antibody Variants

ANTIBODIES TO AMYLOID BETA

POLYOMAVIRUS NEUTRALIZING ANTIBODIES

NOVEL FLT3 ANTIBODIES AND ANTIBODY-DRUG-CONJUGATES BASED THEREON, THERAPEUTIC METHODS AND USES THEREOF IN COMBINATION WITH TYROSINE KINASE INHIBITORS

DESIGNED ANTIBODY-BOUND NANOPARTICLES

HUMANIZED MOUSE MODELS OF THE FCRN RECYCLING PATHWAY

Antibody, Kit, Detection Method and Sample Analyzer for Detecting Thyroid Stimulating Hormone

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

FC POLYPEPTIDE HAVING ALTERED GLYCOSYLATION MODIFICATION

NOVEL ANTI-THYMIDINE KINASE ANTIBODIES

TRISPECIFIC ANTIBODY TARGETING CD79b, CD20, AND CD3

ANTIBODY VARIANTS AND USES THEREOF

BISPECIFIC PD-L1x4-1BB ANTIBODIES AND METHODS OF USE THEREOF

ANTI-TNFR2 SINGLE DOMAIN ANTIBODY, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

ANTIBODIES AGAINST EGFR AND THEIR USES

GUIDED COMBINATIONAL THERAPEUTIC ANTIBODY

ANTI-B7H6 SCFV ANTIBODY, ITS CODING GENES AND THE APPLICATION THEREOF

ANTIBODY-CYTOKINE FUSION PROTEINS AND APPLICATIONS THEREOF

BISPECIFIC PD-L1xCD28 ANTIBODIES AND METHODS OF USE THEREOF

BISPECIFIC ANTIBODY AND USE THEREOF

SIGLEC-8 BINDING PROTEINS AND USES THEREOF

ANTIBODIES TO ANTI-SIGLEC-9 AND MULTISPECIFIC ANTIBODIES TARGETING SIGLEC-7 AND SIGLEC-9

ANTI-LAG3 ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE

CD19 ANTIBODY AND APPLICATION THEREOF

Anti-GPRC5D antibodies and compositions

DLK1 ANTIBODIES AND METHODS OF TREATING CANCER

LEPTIN ANTIBODIES AND METHOD OF REDUCING LEPTIN

ANTI-IL-1-BETA ANTIBODIES

MONOSPECIFIC AND BISPECIFIC ANTIBODIES AND ANTIGEN BINDING FRAGMENTS THEREOF

MONOCLONAL ANTIBODIES SPECIFIC FOR SARS-COV-2 RBD

ANTI-TFR:GAA AND ANTI-CD63:GAA INSERTION FOR TREATMENT OF POMPE DISEASE

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY